EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›NBBK

NBBK

NB Bancorp, Inc.

Next earnings Jul 21, 2026 · consensus $0.48 EPS, $74.7M rev

Last earnings -0.6% on 2026-04-22

Hold
$21.30
▲ +0.80%
$21.30▲ +27.51%
over 1Y
L $16.64EODHDH $22.56
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.8%
1W+4.9%
1M+6.1%
3M+4.8%
YTD+9.8%
1Y+27.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 8 analysts
Buy

Provident deal turbocharges growth but balloons the loan book and ACL — fair price for a transition year, not a steal.

Diluted EPS $1.34 · FY2025

The read

Middling fundamentals offset by an attractive price (~112% below fair value) — worth a look on the value angle.

NB Bancorp is a small eastern-Massachusetts/southern-New Hampshire thrift in the middle of digesting a transformational acquisition. Total assets jumped 35.8% YoY to $7.01B, loans receivable grew from $4.33B to $5.99B, and core deposits expanded from $3.87B to $5.32B — growth rates that don't come from organic banking. The 10-K's risk factors confirm the catalyst: the 'Provident Acquisition' brought goodwill ($18.5M, up from zero) and a sharp jump in core deposit intangible ($19.3M vs. $1.1M). Net income of $50.3M (+19.3%) and diluted EPS of $1.34 (+25.2%) look strong, but EPS growth outran net income because of $77.1M in buybacks against just $5.6M in dividends — capital return is heavily skewed to repurchases even as share count rose 9.0% YoY from acquisition issuance.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue————
Gross profit————
Operating income————
Net income$30.1M$9.82M$42.1M$50.3M
Diluted EPS—$0.23$1.07$1.34
Net margin————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF16.9
PEG (trailing)0.82
Earnings yield5.2%
FCF yield5.9%

Quality & risk

ROIC (est.)—
Free cash flow$57.4M
Total debt—
Net cash$408M

Capital returns

Buyback yield7.9%
Dividend yield (est.)0.6%
Shareholder yield8.5%
Shares Δ YoY+9.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Other event2026-05-21

    Other-events disclosure with exhibits; routine investor/governance update, no material change

  2. 8-K Other event2026-05-13

    Other-events item only; routine corporate disclosure with no financial impact flagged

  3. 10-Q Quarterly report2026-05-08

    Q1'26 10-Q; first full quarter post-Provident integration on the $7B balance sheet

  4. 8-K Shareholder vote2026-04-29

    Annual meeting vote results disclosed; director slate and proposals passed as expected

  5. 8-K Officer / director change2026-04-22

    Q1'26 earnings release plus an officer change; combined results + leadership update

  6. DEF 14A Proxy statement2026-03-27

    Proxy (DEF 14A) for 2026 annual meeting; routine governance, comp and director slate

  7. 10-K Annual report2026-03-03

    FY25 10-K: NI $50.3M +19%, EPS $1.34 +25%, assets +36% from Provident; ACL doubled

  8. 8-K Other event2026-02-04

    Other-events filing with exhibits; non-earnings corporate update, immaterial to thesis

  9. 8-K Earnings results2026-01-22

    Q4'25 earnings release; capped FY25 with NI $50.3M (+19%) and EPS $1.34 (+25%)

Recent filings

all on EDGAR ↗
11-KPeriod ending 2025-12-312026-06-25open ↗8-KPeriod ending 2026-05-212026-05-21open ↗4Period ending 2026-05-152026-05-18open ↗SCHEDULE 13G/AFiling2026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗4/APeriod ending 2026-04-242026-05-15open ↗8-KPeriod ending 2026-05-122026-05-13open ↗10-QPeriod ending 2026-03-312026-05-08open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB+
GrowthA-
ProfitabilityC
Financial healthA-
Momentum—
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$45.24

Undervalued +112% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.34 × (8.5 + 1.5 × 19.3% growth) × 0.90 quality = 33.8× multiple. An estimate, not a price target.

Revenue
—
Net margin
—
ROE
5.9%
P/E
15.9

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$50.3M+19.3%
Diluted EPS$1.34+25.2%
Cash & equivalents$408M+12.0%
Total assets$7.01B+35.8%
Total liabilities$6.15B+39.9%
Stockholders' equity$859M+12.3%
L/E: 7.16x

Frequently asked

Is NB Bancorp, Inc. (NBBK) a buy?
NBBK currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Provident deal turbocharges growth but balloons the loan book and ACL — fair price for a transition year, not a steal.
What is NBBK's fair value?
A Modified-Graham model based on NBBK's SEC fundamentals estimates a fair value of about $45.24. It is an estimate from reported earnings, not a price target.
Is NBBK overvalued or undervalued?
Against a Modified-Graham fair-value estimate, NBBK currently appears undervalued relative to its SEC-grounded earnings power.
What is NB Bancorp, Inc.'s quality score?
NBBK scores 72.17647058823529/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001979330, latest 10-Q filed 2026-05-08) · EODHD · analysis by claude-code · as of 6/25/2026, 2:40:50 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 16 open-market buys · 0 sales

2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy500.00 @ $19.16$9.58K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy133.00 @ $19.17$2.55K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy400.00 @ $19.18$7.67K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy100.00 @ $19.18$1.92K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy767.00 @ $19.18$14.7K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy500.00 @ $19.19$9.60K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy253.00 @ $19.20$4.86K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy100.00 @ $19.21$1.92K
2026-05-15
CAMPANELLI JOSEPH P
President & CEO
Buy247.00 @ $19.21$4.74K
2026-04-24
CAMPANELLI JOSEPH P
President & CEO
Tax24.4K @ $19.82$483K
2026-04-24
CAMPANELLI JOSEPH P
President & CEO
Buy320.00 @ $19.33$6.19K
2026-04-24
CAMPANELLI JOSEPH P
President & CEO
Buy180.00 @ $19.34$3.48K

Dividends

Quarterly
Yield (TTM)
1.3%
Annual / share
$0.28
Last ex-date
2026-05-06
Last amount
$0.07
ex 2026-05-06paid 2026-05-20$0.07
ex 2026-02-05paid 2026-02-19$0.07
ex 2025-11-05paid 2025-11-19$0.07
ex 2025-08-06paid 2025-08-20$0.07

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-22Miss -28.5% est▼ -0.63%8-K ↗
2026-01-22Beat +11.1% est▲ +0.93%8-K ↗
2025-10-22Beat +16.7% est▲ +0.68%8-K ↗
2025-07-23Beat +12.0% est▼ -1.89%8-K ↗
2025-04-22—▲ +2.03%8-K ↗
2025-01-22—▼ -0.39%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
American Express, Bank of America, Mastercard in losers: week's financials wrapBearish
seekingalpha.com· 2026-04-25
NB Bancorp, Inc. (NBBK) Earnings Expected to Grow: Should You Buy?Bullish
finance.yahoo.com· 2026-04-21
NB Bancorp GAAP EPS of $0.19, revenue of $63.2M
seekingalpha.com· 2026-01-23
Why Rivian Stock Rebounded TodayBullish
nasdaq.com· 2025-12-13
Undiscovered Gems in the US Market for December 2025Bullish
finance.yahoo.com· 2025-12-09
Discover 3 Undiscovered Gems In The US MarketBullish
finance.yahoo.com· 2025-11-10

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score72 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity5.9% vs 12.3%
P/E15.9 vs 25.5